Early trial tests new drug for rare, burning pain disorder

This early-stage study is testing whether an investigational drug called BHV-7000 can reduce chronic pain in adults with inherited erythromelalgia, a rare genetic disorder that causes severe burning pain. The study will compare the drug to a placebo in a small group of 5 participants to see if it lowers their pain intensity and reduces the frequency and severity of their pain attacks. Researchers will also closely monitor the drug's safety and how well it is tolerated.